Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells

Pharmacological Research

Volumn 57, Issue 2, 2008, Pages 142-150

  Tahara, Atsuo ^a   Tsukada, Junko ^a   Tomura, Yuichi ^a   Yatsu, Takeyuki ^a   Shibasaki, Masayuki ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Mesangial cells; Transforming growth factor beta; Type IV collagen; V1A receptors; Vasopressin

Indexed keywords

COLLAGEN TYPE 4; SR 121463A PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN V1A RECEPTOR; YM218 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DRUG INHIBITION; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; HYPERTROPHY; KIDNEY DISEASE; MALE; MESANGIUM CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; TIME;

EID: 40149107695     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.01.003     Document Type: Article

References (51)

1. M.W. Steffes R. Osterby B. Chavers S.M. Mauer Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients Diabetes 38 1989 1077 1081
2. E.J. Lewis L.G. Hunsicker R.P. Bain R.D. Rohde The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 1993 1456 1462
3. A. Ji C. Huang C. Liang B. Chen S. Chen W. Sun Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis Cell Mol Immunol 2 2005 150 154
4. P.W. Anderson Y.S. Do W.A. Hsueh Angiotensin II causes mesangial cell hypertrophy Hypertension 21 1993 29 35
5. 1 receptors Kidney Int 45 1994 177 184
6. S. Kagami W.A. Border D.E. Miller N.A. Noble Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells J Clin Invest 93 1994 2431 2437
7. G. Wolf U. Haberstroh E.G. Neilson Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells Am J Physiol 140 1992 95 107
8. R.K. Assoian A. Komoriya C.A. Meyers D.M. Miller M.B. Sporn Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization J Biol Chem 258 1983 7155 7160
9. K. Miyazono U. Hellman C. Wernstedt C.H. Heldin Latent high molecular weight complex of transforming growth factor-β1. Purification from human platelets and structural characterization J Biol Chem 263 1988 6407 6415
10. J. Massague The transforming growth-factor-β family Annu Rev Cell Biol 6 1990 597 647
11. R.A. Ignotz J. Massague Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix J Biol Chem 261 1986 4337 4345
12. D.R. Edwards G. Murphy J.J. Reynolds S.E. Whitham A.J.P. Docherty P. Angel Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor EMBO J 6 1987 1899 1904
13. K. MacKay L.J. Striker J.W. Stauffer T. Doi L.Y. Agodoa G.E. Striker Transforming growth factor-β. Murine glomerular receptors and responses of isolated glomerular cells J Clin Invest 83 1989 1160 1167
14. W.A. Border S. Okuda L.R. Languino E. Ruoslahti Transforming growth factor-β regulates production of proteoglycans by mesangial cells Kidney Int 37 1990 689 695
15. S. Okuda L.R. Languino E. Ruoslahti W.A. Border Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix J Clin Invest 86 1990 453 462
16. W.A. Border S. Okuda L.R. Languino M.B. Sporn E. Ruoslahti Suppression of experimental glomerulonephritis by anti serum against transforming growth factor β1 Nature 346 1990 371 374
17. K. Sharma F.N. Ziyadeh B. Alzahami T.A. Mcgowan S. Kapoor B.R.C. Kurnik Increased renal production of transforming growth factor-β1 in patients with type II diabetes Diabetes 46 1997 854 859
18. 1a vasopressin receptor J Biol Chem 269 1994 3304 3310
19. 1b vasopressin receptor J Biol Chem 269 1994 27088 27092
20. M. Birnbaumer A. Seibold S. Gilbert M. Ishido C. Barberis A. Antaramian Molecular cloning of the receptor for human antidiuretic hormone Nature 357 1992 333 335
21. 1a antagonist, on human vascular smooth muscle cells Am J Physiol 268 1995 H404 H410
22. S. Jard R.C. Gaillard G. Guillon J. Marie P. Schoenenberg A. Muller Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis Mol Pharmacol 30 1986 171 177
23. D. Butlen G. Guillon R.M. Rajerison S. Jard W.H. Sawyer M. Manning Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions Mol Pharmacol 14 1978 1006 1017
24. M.B. Ganz S.K. Pekar M.C. Perfetto R.B. Sterzel Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture Am J Physiol 255 1988 F898 F906
25. 1A receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy Vascular Pharmacol 46 2007 463 469
26. S. Jard C. Lombard J. Marie G. Devilliers Vasopressin receptors from cultured mesangial cells resemble V1a type Am J Physiol 253 1987 F41 F49
27. 1A receptor-selective antagonist YM218 in cultured rat mesangial cells Pharmacology 78 2006 81 90
28. L. Bankir N. Bouby R. Ardaillou D.G. Bichet J.C. Dussaule P. Jungers Progressive increase in plasma vasopressin and decrease in urinary concentrating ability in chronic renal failure: influence of primary disease J Am Soc Nephrol 3 1992 733
29. D.P. Brooks D.F. Nutting J.T. Crofton L. Share Vasopressin in rats with genetic and streptozotocin-induced diabetes Diabetes 38 1989 54 57
30. I. Fujisawa N. Murakami S. Furuto-Kato N. Araki J. Konishi Plasma and neurohypophyseal content of vasopressin in diabetes mellitus J Clin Endocrinol Metab 81 1996 2805 2809
31. M. Kohno T. Horio M. Ikeda K. Yokokawa T. Fukui K. Yasunari Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells Kidney Int 42 1992 860 866
32. M. Kasho M. Sakai T. Sasahara Y. Anami T. Matsumura T. Takemura Serotonin enhances the production of type IV collagen by human mesangial cells Kidney Int 54 1998 1083 1092
33. S.M. Mauer M.W. Steffes E.N. Ellis D.E.R. Sutherland D.M. Brown F.C. Goetz Structural-functional relationships in diabetic nephropathy J Clin Invest 74 1984 1143 1155
34. K. Sharma F.N. Ziyadeh Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-β as a key mediator Diabetes 44 1995 1139 1146
35. M. Rocco Y. Chen S. Goldfarb F.N. Ziyadeh Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule Kidney Int 41 1992 107 114
36. G. Wolf K. Sharma Y. Chen M. Ericksen F.N. Ziyadeh High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β Kidney Int 42 1992 647 656
37. F.N. Ziyadeh K. Sharma M. Erickson G. Wolf Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β J Clin Invest 93 1994 536 542
38. J.S. Bollineni A.S. Reddi Transforming growth factor-β1 enhances glomerular collagen synthesis in diabetic rats Diabetes 42 1993 1673 1677
39. K. Sharma F.N. Ziyadeh Renal hypertrophy is associated with upregulation of TGF-β gene expression in diabetic BB rat and NOD mouse Am J Physiol 267 1994 F1094 F1101
40. T. Yamamoto T. Nakamura N.A. Noble E. Ruoslahti W.A. Border Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy Proc Natl Acad Sci USA 90 1993 1814 1818
41. K. Sharma J. Guo Y. Jin F.N. Ziyadeh Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice Diabetes 45 1996 522 530
42. Y. Yamamoto N.A. Noble A.H. Cohen C.C. Nast A. Hishida L.I. Gold Expression of transforming growth factor-β isoforms in human glomerular diseases Kidney Int 49 1996 461 469
43. K. Yoshioka T. Takemura K. Murakami M. Okada S. Hino H. Miyamoto Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidney Lab Invest 68 1993 154 163
44. R.M. Edwards W. Trizna L.B. Kinter Renal microvascular effects of vasopressin and vasopressin antagonists Am J Physiol 256 1989 F274 F278
45. A. Wolthuis A. Boes H.P. Rodemann J. Grond Vasoactive agents after growth and protein synthesis of cultured rat mesangial cells Kidney Int 41 1992 124 131
46. R.L. Zerbe F. Vinicor G.L. Robertson Plasma vasopressin in uncontrolled diabetes mellitus Diabetes 28 1979 503 508
47. T. Nishikawa M. Omura T. Iizuka I. Saito S. Yoshida Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl-3,4-dihydro-2(1 H )-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus Arzneimitelforschung 46 1996 875 878
48. R. Flaumenhaft M. Abe P. Mignatti D.B. Rifkin Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity J Cell Biol 118 1992 901 909
49. C.V. Prowse J.G. Douglas J.A. Forrest M.L. Forsling Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis Eur J Clin Invest 10 1980 49 54
50. P.M. Mannucci Enhancement of plasminogen activator by vasopressin and adrenaline: a role of cyclic AMP? Thromb Res 4 1974 539 549
51. P.M. Mannucci M. Aberg I.M. Nilsson B. Robertson Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs Br J Haematol 30 1975 81 93